INmune Bio publishes preclinical study on XPro1595 and brain injury

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. MONRY
2. NYXH
3. PNR
4. ONON
5. IAUX
6. KKR
7. LLY
8. DAVA
9. MONC:IM
10. BRKCF

Go back to INmune Bio publishes preclinical study on XPro1595 and brain injury
(NASDAQ: INMB) Delayed: 2.29 --0 (-0%)
Previous Close $2.29    52 Week High $ 
Open $2.29    52 Week Low $ 
Day High $2.29    P/E N/A 
Day Low $2.29    EPS $ 
Volume 420